Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice-Reference-Cited by-同舟云学术

Bone Microenvironment‐Suppressed T Cells Increase Osteoclast Formation and Osteolytic Bone Metastases in Mice

Published:2022-06-17 Issue:8 Volume:37 Page:1446-1463
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J of Bone & Mineral Res

Author:

Arellano Danna L.¹²^ORCID,Juárez Patricia¹³^ORCID,Verdugo‐Meza Andrea¹²^ORCID,Almeida‐Luna Paloma S.¹²,Corral‐Avila Juan A.¹²,Drescher Florian¹²^ORCID,Olvera Felipe⁴,Jiménez Samanta¹,Elzey Bennett D.⁵⁶,Guise Theresa A.³⁷⁸,Fournier Pierrick G.J.¹³^ORCID

Affiliation:

1. Biomedical Innovation Department Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE) Ensenada

2. Posgrado en Ciencias de la Vida Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE) Ensenada Mexico

3. Department of Medicine Indiana University School of Medicine Indianapolis IN

4. Departamento de Biología Molecular y Bioprocesos Instituto de Biotecnología Universidad Nacional Autónoma de México Cuernavaca Mexico

5. Department of Comparative Pathobiology Purdue University West Lafayette IN USA

6. Purdue University Center for Cancer Research Purdue University West Lafayette IN USA

7. Endocrine Neoplasia and Hormone Disorders The University of Texas MD Anderson Cancer Center Houston TX USA

8. Cancer Prevention and Research Institute of Texas Austin TX USA

Funder

American Society for Bone and Mineral Research

Cancer Prevention and Research Institute of Texas

Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California

Consejo Nacional de Ciencia y Tecnología

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4615

Reference57 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Bone metastases

3. Bisphosphonates and other bone agents for breast cancer;O'Carrigan B;Cochrane Database Syst Rev,2017

4. Adjuvant bisphosphonates or RANK-ligand inhibitors for patients with breast cancer and bone metastases: A systematic review and network meta-analysis

5. Cancer immunotherapy: the beginning of the end of cancer?

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterials for bone metastasis;Journal of Controlled Release;2024-09

2. Osteoimmunology in bone malignancies: A symphony with evil;Journal of the National Cancer Center;2024-09

3. The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence;Frontiers in Oncology;2024-08-01

4. MDSCs in bone metastasis: Mechanisms and therapeutic potential;Cancer Letters;2024-06

5. Breast Tumor Metastasis and Its Microenvironment: It Takes Both Seed and Soil to Grow a Tumor and Target It for Treatment;Cancers;2024-02-23